{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-130464","form_type":"8-K","ticker":null,"cik":"0001466301","company_name":"Clovis Oncology, Inc.","filed_at":"2023-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.948342+00:00","generated_at":"2026-06-16T04:52:44.883097+00:00","sec_items":["2.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Clovis Oncology completes sale of Rubraca assets to pharma& Schweiz under Chapter 11","bullets":["On May 1, 2023, Clovis closed the Rubraca asset sale to pharma& Schweiz GmbH, following court approval on April 12.","Common stockholders are not expected to receive any payment due to senior creditor claims.","Sale was part of Chapter 11 bankruptcy proceedings initiated in December 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-130464","json":"https://secwatch.observer/filing/0001193125-23-130464.json","markdown":"https://secwatch.observer/filing/0001193125-23-130464.md","text":"https://secwatch.observer/filing/0001193125-23-130464.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1466301/000119312523130464/0001193125-23-130464-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1466301/000119312523130464/d489588d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T04:52:44.883097+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"27233faae4ebbc78199c117520b6691d118ca101","claim":"Clovis Oncology, Inc. completed a disposition involving pharma& Schweiz GmbH (closed 2023-05-01).","evidence_excerpt":"On May 1, 2023, the Company and Pharma& consummated the Rubraca Sale Transaction.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1466301/000119312523130464/0001193125-23-130464-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"pharma& Schweiz GmbH"},{"label":"Closing","value":"2023-05-01"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}